Clearview Wealth Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-41
Closed -$1.51K 189
2023
Q2
$1.51K Hold
41
﹤0.01% 556
2023
Q1
$1.23K Sell
41
-183
-82% -$6.03K ﹤0.01% 559
2022
Q4
$6.86K Hold
224
0.01% 365
2022
Q3
$6K Sell
224
-230
-51% -$7.59K ﹤0.01% 388
2022
Q2
$15K Buy
454
+1
+0.2% +$37 0.01% 310
2022
Q1
$14K Buy
453
+2
+0.4% +$63 0.01% 339
2021
Q4
$15K Sell
451
-134
-23% -$4.17K 0.01% 361
2021
Q3
$17K Buy
585
+2
+0.3% +$65 0.01% 355
2021
Q2
$20K Sell
583
-545
-48% -$18K 0.01% 337
2021
Q1
$32K Buy
1,128
+237
+27% +$6.31K 0.02% 275
2020
Q4
$22K Buy
+891
New +$21.2K 0.01% 292

Other funds holding CC

Clearview Wealth Advisors's CC Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of Chemours (CC) in Q3 2023, closing a stake of 41 shares — an estimated $1.51K sold.

Clearview Wealth Advisors first reported a position in CC in Q4 2020 and held it in 11 quarters. The position peaked at $32K in Q1 2021. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • Clearview Wealth Advisors reported no remaining Chemours position as of Q3 2023 after selling out during the quarter.
  • Clearview Wealth Advisors sold 41 Chemours shares in Q3 2023, an estimated $1.51K.
  • Clearview Wealth Advisors first reported a position in Chemours in Q4 2020 and held it in 11 quarters.
  • Clearview Wealth Advisors's Chemours position peaked at $32K in Q1 2021.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.